Cardiac sodium channel diseases.

Area of Science:

• Cardiovascular Genetics
• Molecular Cardiology
• Channelopathies

Background:

• SCN5A gene mutations are linked to Long QT syndrome type 3 (LQT3), Brugada syndrome (BrS), and Lev-Lenegre syndrome.
• These conditions involve inherited cardiac arrhythmias and sudden death.
• Initial research focused on specific mutations, but complexity emerged.

Purpose of the Study:

• To explore the complex structure-function relationships of the SCN5A protein.
• To investigate the diverse mechanisms underlying cardiac excitability defects caused by SCN5A mutations.
• To re-evaluate the classification of SCN5A-related channelopathies.

Main Methods:

• Genotype-phenotype correlation studies.
• In vitro expression studies of SCN5A mutations.
• Biophysical characterization of cardiac sodium channel defects.

Main Results:

• SCN5A mutations result in a wide range of cardiac phenotypes beyond LQT3, BrS, and Lev-Lenegre syndrome.
• Single amino acid substitutions can significantly alter cardiac excitability through various mechanisms.
• Overlapping clinical presentations were observed in patients with SCN5A mutations.

Conclusions:

• The traditional classification of SCN5A-related channelopathies requires revision.
• A unified concept of
• sodium channel syndrome
• is proposed, encompassing a spectrum of phenotypes.
• Understanding these genotype-phenotype correlations is crucial for diagnosing and managing inherited arrhythmias.